ArticleDrug design, development and therapy2025
Abnormally Activated MNX1 Promotes Tumor Growth and Osimertinib Resistance and Predicts Survival in EGFR-Mutant Lung Adenocarcinoma.
Weiguo Gu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.